Assessment of Potential Interactions Between GBR 12909 and Cocaine - 1

• Status: Unknown status
• Trial end date: 2005-06-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to assess potential interactions between intravenous (IV) cocaine and 3 doses of GBR 12909.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: National Institute on Drug Abuse (NIDA)
• Treatments: Cocaine; Vanoxerine

Criteria

Inclusion Criteria:

• Must be within 20% ideal body weight and must weigh at least 45 kg.

• Must understand the study procedures and provide written informed consent.

• Must meet DSM-4 criteria and are non-treatment seeking at time of study.

Exclusion Criteria:

• Please contact study site for more information